ANXA2 and neoplasm: The findings revealed that C1 CALR+MCs, C2 ALOX5+MCs, C3 ANXA2+MCs, C5 IL32+MCs, myeloid cells, fibroblasts, and SMCs are capable of targeting tumor cells by releasing TWEAK.